Overview
Company Profile
Valuation
Key Metrics
Moving Averages
Earnings
Past Earnings
In Context
Company News
To Understand This
To Understand This
Claude writes a second opinion independent of the site's own analysis; while the market is open it reads the live price.
Claude reads this company in two focuses: technical (1–2 weeks) and stock picking (3–6 months). While the market is open it takes the live price.
These five buckets are the 12-month ratings of the analysts covering the stock. They are not a price target and they say nothing about timing. Ratings move slowly and in step, so the distribution usually turns after the price rather than before it.
No Data
This data isn't available right now.
The buy-side share rose 3 points in 3 months: 82% → 85%.
| Analyst Ratings | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Change |
|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 0 |
| Buy | 5 | 7 | 7 | 7 | +2 |
| Hold | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell |
Net change in the monthly distribution: a rise in a bucket can come from an analyst changing their rating or a new one joining. Individual rating changes and price targets are not in the source.
FinnhubUpdated October 25 09:50 NY
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| Total | 11 | 13 | 13 | 13 | +2 |
|---|
| Buy Side | 82% | 85% | 85% | 85% |
|---|
| Period | Report Date | Surprise | EPS · Forecast | EPS · Actual |
|---|---|---|---|---|
| Q2 2026Aug 10, 2026 | − $0.27 | − $1.65 | − $1.92 | |
| Q1 2026 | + $0.40 | − $1.96 | − $1.56 | |
| Q4 2025 | + $0.11 | − $0.18 | − $0.07 | |
| Q3 2025 | − $0.39 | − $0.32 | − $0.71 |
EPS (Earnings Per Share)
Ask what you want to know about this stock; Claude answers only from the data on this page and gives no buy or sell advice. Sign in to ask.
Data an Answer Can Draw OnLast SessionValuationAnalyst RatingsEarnings HistoryHeadlines
Answers are written with Claude only from this page's data and the last completed session's close; every number in an answer must appear in that data. Not investment advice.
We don't have this company's sub-industry, so the line-of-business criterion wasn't screened.
It is an automated pre-screen based on the line of business and AAOIFI's widely used financial thresholds; a final judgement rests with your own school of thought and the certification boards that audit the filings.
The interest-income test (5% of revenue) needs a revenue breakdown our free data source doesn't provide, so that criterion isn't screened.
No Data
This data isn't available right now.
Couldn't load data
The provider isn't responding; this card is empty for now.

GUTSHealth Care
$0.98
Alpaca · SIPUpdated 10:06 NY15 Minutes DelayedMay Be Out Of Date
FinnhubUpdated October 25 09:50 NY
Pivot Levels
Indicators are computed from the last completed session's close and carry no opinion; the same calculation feeds the stocks on the Technical Analysis page. The 50, 100 and 200-day averages are in the Valuation section.
Alpaca · SIPUpdated 08:32 NY15 Minutes DelayedMay Be Out Of Date
Average close over the last 50, 100 and 200 trading days. Above the average, buyers led that stretch; below it, sellers did. The percentage next to it is the gap.